---
reference_id: "PMID:19059503"
title: Compound-heterozygous Marfan syndrome.
authors:
- Van Dijk FS
- Hamel BC
- Hilhorst-Hofstee Y
- Mulder BJ
- Timmermans J
- Pals G
- Cobben JM
journal: Eur J Med Genet
year: '2009'
doi: 10.1016/j.ejmg.2008.11.004
content_type: abstract_only
---

# Compound-heterozygous Marfan syndrome.
**Authors:** Van Dijk FS, Hamel BC, Hilhorst-Hofstee Y, Mulder BJ, Timmermans J, Pals G, Cobben JM
**Journal:** Eur J Med Genet (2009)
**DOI:** [10.1016/j.ejmg.2008.11.004](https://doi.org/10.1016/j.ejmg.2008.11.004)

## Content

1. Eur J Med Genet. 2009 Jan-Feb;52(1):1-5. doi: 10.1016/j.ejmg.2008.11.004. Epub
 2008 Nov 27.

Compound-heterozygous Marfan syndrome.

Van Dijk FS(1), Hamel BC, Hilhorst-Hofstee Y, Mulder BJ, Timmermans J, Pals G, 
Cobben JM.

Author information:
(1)Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The 
Netherlands. fs.vandijk2@vumc.nl

We report two families in which the probands have compound-heterozygous Marfan 
syndrome (MFS). The proband of family 1 has the R2726W FBN1 mutation associated 
with isolated skeletal features on one allele and a pathogenic FBN1 mutation on 
the other allele. The phenotype of the compound-heterozygous probands appears to 
be more severe than that of their heterozygous family members which underlines 
the possibility that certain trans-located FBN1 mutations might act as modifiers 
of phenotype explaining some of the intrafamilial variability in Marfan 
syndrome.

DOI: 10.1016/j.ejmg.2008.11.004
PMID: 19059503 [Indexed for MEDLINE]